| ［1］ Langlois S, Brock JA, Genetics Committee, et al. Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma［J］. J Obstet Gynaecol Can,2013,35(2):177-183.［2］ Centers for Disease Control and Prevention. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee［J］. MMWR Recomm Rep,1990,39(RR-2):1-26. ［3］ Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fuid and cord blood［J］. Am J Obstet Gynecol 2001,184(7):1514-1518. ［4］ Alexander JM, Ramus R, Jackson G, et al. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers［J］. Infect Dis Obstet Gynecol, 1999,7(6):283-286. ［5］ Ko TM, Tseng LH, Chang MH, et al. Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection［J］. Arch Gynecol Obstet, 1994,255(1):25-30. ［6］ Healy CM, Cafferkey MT, Conroy A, et al. Hepatitis C infection in an Irish antenatal population［J］. Ir J Med Sci, 2000,169:180-182. ［7］ Blasig A, Wagner EC, Pi D, et al. Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods［J］. Can J Public Health, 2011,102(2):98-102. ［8］ Conte D, Fraquelli M, Prati D, et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women［J］. Hepatology, 2000,31(3):751-755. ［9］ Foster GR, Tudor-Williams G, White J, et al. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus［J］. BJOG,2003,110(1):371-377. ［10］ Delamare C, Carbonne B, Heim N, et al. Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study［J］. J Hepatol，1999,31(3):416-420. ［11］ Minola E, Maccabruni A, Pacati I,et al. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus［J］. Hepatology, 2001,33(5):1341-1342.［12］ Loutfy MR, Margolese S, Money DM, et al. Canadian HIV Pregnancy Planning Guidelines［J］. J Obstet Gynaecol Can, 2012，34(6):575-590. ［13］ Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group［J］. Am J Obstet Gynecol, 1996,175(3):661-667. ［14］ López M, Coll O. Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations ［J］. Fetal Diagn Ther，2010，28(1):1-8. ［15］ Ducarme G, Ceccaldi PF, Bernuau J, et al. Amniocentesis and viral risk (hepatitis B, C and HIV) ［J］. J Gynecol Obstet Biol Reprod, 2009,38(6):469-473.［16］ Somigliana E, Bucceri AM, Tibaldi C, et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series［J］. Am J Obstet Gynecol, 2005,193(2):437-442. ［17］ de Ruiter A, Taylor GP, Clayden P,et al. British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review) ［J］. HIV Med, 2014,15(Suppl.4):1-77.［18］ Westling K, Pettersson K, Kaldma A, et al. Rapid decline in HIV viral load when introducing raltegravir-containing antiretroviral treatment late in pregnancy［J］. AIDS Patient Care STDS, 2012,26(12):714-717. ［19］ Giorlandino C, Gambuzza G, D’Alessio P, et al. Blood contamination of amniotic fuid after amniocentesis in relation to placental location［J］. Prenat Diagn 1996,16(2):180–182. （2015-04-10收稿 2015-05-11修回） |
